These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 16209208)

  • 1. [Clinical study of Eviprostat for the treatment of benign prostatic hyperplasia].
    Song Y; Li NC; Wang XF; Ma LL; Wan B; Hong BF; Na YQ
    Zhonghua Nan Ke Xue; 2005 Sep; 11(9):674-6. PubMed ID: 16209208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-blind, randomized controlled study of the clinical and urodynamic effects of an alpha-blocker (naftopidil) and phytotherapy (eviprostat) in the treatment of benign prostatic hyperplasia.
    Yamanishi T; Yasuda K; Kamai T; Tsujii T; Sakakibara R; Uchiyama T; Yoshida K
    Int J Urol; 2004 Jul; 11(7):501-9. PubMed ID: 15242359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fushile: a safe and effective therapeutic for benign prostatic hyperplasia].
    Shang XJ; Liu ZY; Liu ZF; Sun YH; Huang YF
    Zhonghua Nan Ke Xue; 2008 Mar; 14(3):227-30. PubMed ID: 18488335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of supplemental administration of Eviprostat in patients with benign prostatic hyperplasia with persistent symptoms following treatment with alpha1-adrenoceptor blocker].
    Naruoka T; Suzuki Y; Furuta A; Endo K; Sugaya S; Egawa S
    Hinyokika Kiyo; 2008 May; 54(5):341-4. PubMed ID: 18546857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A comparative study on different doses of cernilton for preventing the clinical progression of benign prostatic hyperplasia].
    Xu J; Qian WQ; Song JD
    Zhonghua Nan Ke Xue; 2008 Jun; 14(6):533-7. PubMed ID: 18649754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eviprostat suppresses urinary oxidative stress in a rabbit model of partial bladder outlet obstruction and in patients with benign prostatic hyperplasia.
    Matsumoto S; Hanai T; Matsui T; Oka M; Tanaka M; Uemura H
    Phytother Res; 2010 Feb; 24(2):301-3. PubMed ID: 19585469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Assessment of clinical usefulness of Eviprostat for benign prostatic hyperplasia--comparison of Eviprostat tablet with a formulation containing two-times more active ingredients].
    Tamaki M; Nakashima M; Nishiyama R; Ikeda H; Hiura M; Kanaoka T; Nakano T; Hayashi T; Ogawa O
    Hinyokika Kiyo; 2008 Jun; 54(6):435-45. PubMed ID: 18634442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Conservative treatment of benign prostatic hypertrophy: reevaluation of the effect of eviprostat by subjective symptoms and uroflowmetry].
    Matsuura T; Wakabayashi A; Kaneko S; Kurita T
    Hinyokika Kiyo; 1986 Jun; 32(6):903-6. PubMed ID: 2429533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effectiveness and safety of naftopidil for benign prostatic hyperplasia patients with overactive bladder symptoms].
    Ge JP; Gong J; Ma HQ; Wei W; Shang XJ; Zhang ZY; Xu S; Wang D; Gao JP
    Zhonghua Nan Ke Xue; 2008 Oct; 14(10):927-30. PubMed ID: 19157107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicentric, placebo-controlled, double-blind clinical trial of beta-sitosterol (phytosterol) for the treatment of benign prostatic hyperplasia. German BPH-Phyto Study group.
    Klippel KF; Hiltl DM; Schipp B
    Br J Urol; 1997 Sep; 80(3):427-32. PubMed ID: 9313662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of tamsulosin hydrochloride compared to doxazosin in the treatment of Indonesian patients with lower urinary tract symptoms due to benign prostatic hyperplasia.
    Rahardjo D; Soebadi DM; Sugandi S; Birowo P; Djati W; Wahyudi I
    Int J Urol; 2006 Nov; 13(11):1405-9. PubMed ID: 17083392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The clinical efficacy of Naftopidil tablet in the treatment of benign prostatic hyperplasia].
    Ju XB; Wu HF; Su JT
    Zhonghua Nan Ke Xue; 2002; 8(4):286-8. PubMed ID: 12491697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A pilot study of photon therapy for benign prostate hyperplasia (a report of 30 cases)].
    Mo Z; Huang H; Long D; Yang Z
    Zhonghua Nan Ke Xue; 2004 Oct; 10(10):764-6, 770. PubMed ID: 15562792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The clinical efficacy of epristeride in the treatment of benign prostatic hyperplasia].
    Ju XB; Wu HF; Hua LX; Zhang W; Li J
    Zhonghua Nan Ke Xue; 2002; 8(1):42-4. PubMed ID: 12479047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical impact of tamsulosin on generic and symptom-specific quality of life for benign prostatic hyperplasia patients: using international prostate symptom score and Rand Medical Outcomes Study 36-item Health Survey.
    Suzuki H; Yano M; Awa Y; Nakatsu H; Egoshi K; Mikami K; Ota S; Okano T; Hamano S; Ohki T; Furuya Y; Ichikawa T
    Int J Urol; 2006 Sep; 13(9):1202-6. PubMed ID: 16984553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up study to evaluate the efficacy and safety of the doxazosin gastrointestinal therapeutic system in patients with benign prostatic hyperplasia with or without concomitant hypertension.
    Chung BH; Hong SJ
    BJU Int; 2006 Jan; 97(1):90-5. PubMed ID: 16336335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaporesection for managing benign prostatic hyperplasia using a 2-microm continuous-wave laser: a prospective trial with 1-year follow-up.
    Fu WJ; Hong BF; Yang Y; Zhang X; Gao JP; Zhang L; Wang XX
    BJU Int; 2009 Feb; 103(3):352-6. PubMed ID: 18778340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-blind, randomized controlled study of the clinical and urodynamic effects of an alpha-blocker (naftopidil) and phytotherapy (eviprostat) in the treatment of benign prostatic hyperplasia.
    Kaplan SA
    J Urol; 2005 Sep; 174(3):1011. PubMed ID: 16094031
    [No Abstract]   [Full Text] [Related]  

  • 19. A randomised, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia.
    Stief CG; Porst H; Neuser D; Beneke M; Ulbrich E
    Eur Urol; 2008 Jun; 53(6):1236-44. PubMed ID: 18281145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photoselective vaporization of the prostate in the treatment of benign prostatic hyperplasia.
    Fu WJ; Hong BF; Yang Y; Cai W; Gao JP; Wang CY; Wang XX
    Chin Med J (Engl); 2005 Oct; 118(19):1610-4. PubMed ID: 16232345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.